Editorial Comment to Phase I/II study of multipeptide cancer vaccine IMA901 after single-dose cyclophosphamide in Japanese patients with advanced renal cell cancer with long-term follow up.

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

Keyphrases